Definitions of Tuberculosis, Multidrug-Resistant TB (MDR TB) and Extensively Drug-Resistant TB (XDR TB)
View Drug-Resistant TB — A Visual Tour
History of TBCausesTransmissionSymptomsDiagnosisTreatmentPreventionTB and HIVGeneral Publications
An ancient disease, TB remains one of the major causes of disability and death worldwide. In 2006, 9.2 million new cases of TB emerged and TB killed 1.7 million people. NIAID is examining TB at its fundamental levels through research aimed at developing faster diagnostic tools, better vaccines, and shorter treatment times.
Multidrug-resistant and Extensively Drug-resistant Tuberculosis Research Agenda (PDF)
NIAID’s Role in Addressing Tuberculosis (TB), Drug-Resistant TB, and TB in People with HIV/AIDS
Research Goals Understanding TB Diagnostic Research Advances in TreatmentPrevention: Vaccine DevelopmentScientific Illustrations of Drug-Resistant TB
NIAID LabsNetworks, Consortia and PartnersResourcesTrainingMeeting SummariesScientific Publications
NIAID Describes Research Priorities to Fight Drug-Resistant Tuberculosis - Apr. 22, 2008
Statement of Christine F. Sizemore, Ph.D., Barbara E. Laughon, Ph.D., and Anthony S. Fauci, M.D. on World TB Day - Mar. 24, 2008
NIAID Media Availability: Promising New TB Drug Given Special Status by U.S. and European Regulators - Oct. 24, 2007
NIAID Media Availability: NIAID Releases MDR/XDR Tuberculosis Research Agenda - June 6, 2007
All TB News Releases
TB is an old disease, but one that still ranks among the foremost killers of the 21st century.Read more.
Volunteer for NIAID-funded clinical studies related to antimicrobial (drug) resistance by going to ClinicalTrials.gov.
Global Research, Africa